Literature DB >> 23225909

Evaluation of the 7th American Joint Committee on cancer TNM staging system for prostate cancer in point of classification of bladder neck invasion.

Mun Su Chung1, Seung Hwan Lee, Dong Hoon Lee, Byung Ha Chung.   

Abstract

OBJECTIVE: To assess the validity of the 7th edition of the American Joint Committee on Cancer TNM staging system for prostate cancer, paying special attention to bladder neck invasion, in an Asian population.
METHODS: Clinicopathologic data of 368 men who underwent radical prostatectomy between 2003 and 2011 at our institution were reviewed. The main interest of this study was to confirm that both isolated positive bladder neck margin and positive bladder neck margin associated with other surgical margin have more favorable biochemical outcomes than seminal vesicle invasion (pT3b).
RESULTS: The 3-year biochemical recurrence-free survival for men with organ confined disease, extraprostatic extension, isolated positive bladder neck margin, positive bladder neck margin with other surgical margin and seminal vesicle invasion was 88.9, 74.8, 51.2, 19.4 and 18.8%, respectively. On multivariate analysis, the increased risk of progression associated with an isolated positive bladder neck margin (hazard ratio 4.34, 95% confidence interval 1.40-13.46, P = 0.011) was less than that of seminal vesicle invasion (hazard ratio 9.67, 95% confidence interval 3.70-25.25, P < 0.001). As for the positive bladder neck margin with other surgical margin, the increased risk of progression (hazard ratio 9.32, 95% confidence interval 3.50-24.82, P < 0.001) was similar to that of men with seminal vesicle invasion.
CONCLUSIONS: In our study, men with isolated positive bladder neck margin and positive bladder neck margin plus other surgical margin had no worse biochemical outcomes than those with seminal vesicle invasion (pT3b). It is reasonable to classify prostate cancer with bladder neck invasion (the 6th American Joint Committee on Cancer edition pT4 category) into the 7th edition pT3 category.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23225909     DOI: 10.1093/jjco/hys196

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  6 in total

1.  Rapid progression of mixed neuroendocrine carcinoma-acinar adenocarcinoma of the prostate: A case report.

Authors:  Jingchao Wei; Xiaoping Zheng; Liuxun Li; Wensu Wei; Zhi Long; Leye He
Journal:  Oncol Lett       Date:  2016-06-16       Impact factor: 2.967

2.  SPAG9 promotes prostate cancer proliferation and metastasis via MAPK signaling pathway.

Authors:  Chutian Xiao; Mingzhao Li; Qunxiong Huang; Jie Si-Tu
Journal:  Am J Transl Res       Date:  2019-08-15       Impact factor: 4.060

3.  Chromodomain helicase/ATPase DNA binding protein 1-like protein expression predicts poor prognosis in nasopharyngeal carcinoma.

Authors:  Fa-Ren Su; Jing-Hua Ding; Lin Bo; Xin-Gang Liu
Journal:  Exp Ther Med       Date:  2014-10-13       Impact factor: 2.447

Review 4.  Diagnosis of prostate cancer via nanotechnological approach.

Authors:  Benedict J Kang; Minhong Jeun; Gun Hyuk Jang; Sang Hoon Song; In Gab Jeong; Choung-Soo Kim; Peter C Searson; Kwan Hyi Lee
Journal:  Int J Nanomedicine       Date:  2015-10-19

5.  HCRP-1 regulates cell migration, invasion and angiogenesis via Src/ FAK signaling in human prostate cancer.

Authors:  Feifei Chen; Jianqiang Wu; Jingwei Teng; Wang Li; Junnian Zheng; Jin Bai
Journal:  Int J Biol Sci       Date:  2020-01-01       Impact factor: 6.580

6.  Role of RUNX3 in suppressing metastasis and angiogenesis of human prostate cancer.

Authors:  Feifei Chen; Meng Wang; Jin Bai; Qinghua Liu; Yaguang Xi; Wang Li; Junnian Zheng
Journal:  PLoS One       Date:  2014-01-24       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.